Merck To Move Ahead on a Heart Drug Where Pfizer Failed


Published On: May 12th, 2010

Merck today highlighted cardiovascular pipeline with six molecules in late-stage development. Among them: anacetrapib — a molecular cousin to a drug Pfizer once had in development.

Here is the original post: 
Merck To Move Ahead on a Heart Drug Where Pfizer Failed



Loading...


Comments are closed.